Skip to main content
. 2020 Jan 24;69(4):663–675. doi: 10.1007/s00262-020-02483-1

Table 2.

Drug-related adverse events

N = 26 Any grade Grade 3
Injection site reaction 26 0
Hypertension 8 5
Malaise 3 0
Sinus tachycardia 3 0
LDH increased 3 0
Hyperkalemia 3 0
Hypertriglyceridemia 3 0
Chills 2 0
QTc interval prolongation 2 0
Platelet count decreased 2 0
ALT increased 2 0
Fibrinogen increased 2 0
FDP increased 2 0
Anorexia 1 1

Grade 1 anemia, increased ALP, decreased APTT, increased CPK, dysgeusia, hypokalemia, hyponatremia, infection (herpes zoster virus), decreased lymphocyte count and sore throat were observed in 1 patient each. No grade 4–5 drug-related AEs were observed

ALT alanine aminotransferase, FDP fibrin degradation products, LDH lactate dehydrogenase